TRDA($265M) has a higher market cap than NAGE($241M). NAGE has higher P/E ratio than TRDA: NAGE (16.00) vs TRDA (10.26). TRDA YTD gains are higher at: -33.852 vs. NAGE (-52.201). NAGE has higher annual earnings (EBITDA): 10.3M vs. TRDA (-172.76M). TRDA has more cash in the bank: 223M vs. NAGE (66.7M). NAGE has less debt than TRDA: NAGE (2.33M) vs TRDA (48.5M). NAGE has higher revenues than TRDA: NAGE (129M) vs TRDA (4.69M).

	NAGE	TRDA	NAGE / TRDA
Capitalization	241M	265M	91%
EBITDA	10.3M	-172.76M	-6%
Gain YTD	-52.201	-33.852	154%
P/E Ratio	16.00	10.26	156%
Revenue	129M	4.69M	2,753%
Total Cash	66.7M	223M	30%
Total Debt	2.33M	48.5M	5%

FUNDAMENTALS RATINGS

NAGE: Fundamental Ratings

	NAGE
OUTLOOK RATING 1..100	83
VALUATION overvalued / fair valued / undervalued 1..100	63 Fair valued
PROFIT vs RISK RATING 1..100	100
SMR RATING 1..100	45
PRICE GROWTH RATING 1..100	79
P/E GROWTH RATING 1..100	97
SEASONALITY SCORE 1..100	n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS

Technical Analysis

	NAGE	TRDA
RSI ODDS (%)	N/A	N/A
Stochastic ODDS (%)	2 days ago 74%	2 days ago 90%
Momentum ODDS (%)	2 days ago 87%	2 days ago 83%
MACD ODDS (%)	2 days ago 84%	2 days ago 86%
TrendWeek ODDS (%)	2 days ago 86%	2 days ago 86%
TrendMonth ODDS (%)	2 days ago 86%	2 days ago 86%
Advances ODDS (%)	18 days ago 75%	11 days ago 86%
Declines ODDS (%)	3 days ago 83%	3 days ago 84%
BollingerBands ODDS (%)	2 days ago 88%	2 days ago 90%
Aroon ODDS (%)	2 days ago 87%	5 days ago 89%

COMPARISON

Comparison

Sep 12, 2026

Stock price -- (NAGE: $3.04 vs. TRDA: $6.80)

Brand notoriety: NAGE and TRDA are both not notable

NAGE represents the Food: Major Diversified, while TRDA is part of the Biotechnology industry

Current volume relative to the 65-day Moving Average: NAGE: 45% vs. TRDA: 77%

Market capitalization -- NAGE: $240.54M vs. TRDA: $264.77M

NAGE [@Food: Major Diversified] is valued at $240.54M. TRDA’s [@Biotechnology] market capitalization is $264.77M. The market cap for tickers in the [@Food: Major Diversified] industry ranges from $68.52K to $255.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Food: Major Diversified] industry is $3.06B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAGE’s FA Score shows that 0 FA rating(s) are green while TRDA’s FA Score has 0 green FA rating(s).

NAGE’s FA Score: 0 green, 5 red.
TRDA’s FA Score: 0 green, 5 red.

According to our system of comparison, NAGE is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAGE’s TA Score shows that 2 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

NAGE’s TA Score: 2 bullish, 6 bearish.
TRDA’s TA Score: 4 bullish, 5 bearish.

According to our system of comparison, TRDA is a better buy in the short-term than NAGE.

Price Growth

NAGE (@Food: Major Diversified) experienced а -4.10% price change this week, while TRDA (@Biotechnology) price change was -4.63% for the same time period.

The average weekly price growth across all stocks in the @Food: Major Diversified industry was -2.77%. For the same industry, the average monthly price growth was -8.08%, and the average quarterly price growth was -11.01%.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

NAGE is expected to report earnings on Nov 04, 2026.

TRDA is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Food: Major Diversified (-2.77% weekly)

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three

NAGE

Daily Signal:

Gain/Loss:

TRDA

Setup

Daily Signal:

Description

Gain/Loss:

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
GGOTX	14.15	N/A	N/A
Goldman Sachs Mid Cap Growth Inv
PRIGX	24.88	N/A	N/A
T. Rowe Price Glbl Val Eq Cl I
OBSIX	37.24	N/A	N/A
Oberweis Small-Cap Opportunities Instl
FTYCX	55.41	N/A	N/A
FullerThaler Behavioral Sm-Cp Eq C
LZSIX	14.66	N/A	N/A
Lazard International Equity Select Instl

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been closely correlated with ENGN. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRDA jumps, then ENGN could also see price increases.

Ticker / NAME	Correlation To TRDA	1D Price Change %
TRDA	100%	+5.92%
ENGN - TRDA	78% Closely correlated	+1.69%
INSM - TRDA	44% Loosely correlated	+1.67%
KRRO - TRDA	42% Loosely correlated	+5.74%
MREO - TRDA	40% Loosely correlated	+14.47%
PHAR - TRDA	40% Loosely correlated	+6.26%
More